Cargando…

Serum Response Factor Controls CYLD Expression via MAPK Signaling Pathway

Tumor suppressor gene CYLD is a deubiquitinating enzyme which negatively regulates various signaling pathways by removing the lysine 63-linked polyubiquitin chains from several specific substrates. Loss of CYLD in different types of tumors leads to either cell survival or proliferation. In this stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Gang, Ahlqvist, Kristofer, Pannem, Rajeswararao, Posern, Guido, Massoumi, Ramin
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088714/ https://www.ncbi.nlm.nih.gov/pubmed/21573132 http://dx.doi.org/10.1371/journal.pone.0019613

Ejemplares similares

CYLD and SUMO in neuroblastoma therapy
por: Masoumi, Katarzyna Chmielarska, et al.
Publicado: (2016)

UVB radiation represses CYLD expression in melanocytes
por: Kuphal, Silke, et al.
Publicado: (2017)

Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer
por: Masoumi, K. C., et al.
Publicado: (2011)

Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma
por: Massoumi, Ramin, et al.
Publicado: (2009)

CASPASE 8 inhibits programmed necrosis by processing CYLD
por: O’Donnell, Marie Anne, et al.
Publicado: (2011)

CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin
por: Wickström, Sara A, et al.
Publicado: (2010)

CYLD Enhances Severe Listeriosis by Impairing IL-6/STAT3-Dependent Fibrin Production
por: Nishanth, Gopala, et al.
Publicado: (2013)

Nemo-like kinase regulates the expression of vascular endothelial growth factor (VEGF) in alveolar epithelial cells
por: Ke, Hengning, et al.
Publicado: (2016)

The E3 ligase Itch and deubiquitinase Cyld co-operatively regulate Tak1 and inflammation
por: Ahmed, Neesar, et al.
Publicado: (2011)

PKCθ/β and CYLD Are Antagonistic Partners in the NFκB and NFAT Transactivation Pathways in Primary Mouse CD3(+) T Lymphocytes
por: Thuille, Nikolaus, et al.
Publicado: (2013)

SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling
por: Elliott, Paul R., et al.
Publicado: (2016)

Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD
por: Hövelmeyer, Nadine, et al.
Publicado: (2007)

SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes
por: Kupka, Sebastian, et al.
Publicado: (2016)

Hematopoietic stem cell quiescence and function are controlled by the CYLD–TRAF2–p38MAPK pathway
por: Tesio, Melania, et al.
Publicado: (2015)

The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway
por: Zhang, Lele, et al.
Publicado: (2018)

CYLD in health and disease
por: Marín-Rubio, José L., et al.
Publicado: (2023)

CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt
por: Lim, Jae Hyang, et al.
Publicado: (2012)

Syndecan-4 negatively regulates antiviral signalling by mediating RIG-I deubiquitination via CYLD
por: Lin, Wei, et al.
Publicado: (2016)

A novel large deletion of the CYLD gene causes CYLD cutaneous syndrome in a Chinese family
por: Zhu, Ruizheng, et al.
Publicado: (2020)

An siRNA library screen identifies CYLD and USP34 as deubiquitinases that regulate GPCR-p38 MAPK signaling and distinct inflammatory responses
por: Cheng, Norton, et al.
Publicado: (2023)

Expression of CYLD and NF-κB in Human Cholesteatoma Epithelium
por: Byun, Jae Yong, et al.
Publicado: (2010)

Relationship between clinicopathological characteristics and CYLD expression in patients with cholesteatoma
por: Miyake, Shunsuke, et al.
Publicado: (2020)

SCF(β-TRCP) regulates osteoclastogenesis via promoting CYLD ubiquitination
por: Wu, Xiaomian, et al.
Publicado: (2014)

CYLD tumour supressor regulates ciligenesis
por: Eguether, T, et al.
Publicado: (2012)

Dysregulated TRK Signalling is a Therapeutic Target in CYLD Defective Tumours
por: Rajan, Neil, et al.
Publicado: (2011)

CYLD Regulates Noscapine Activity in Acute Lymphoblastic Leukemia via a Microtubule-Dependent Mechanism
por: Yang, Yunfan, et al.
Publicado: (2015)

The Role of Leukotriene Receptor Signaling in Inflammation and Cancer
por: Massoumi, Ramin, et al.
Publicado: (2007)

The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate Notch signalling
por: Rajan, Neil, et al.
Publicado: (2014)

The cylindromatosis (CYLD) gene and head and neck tumorigenesis
por: Verhoeft, Krista Roberta, et al.
Publicado: (2016)

Genetic Testing in CYLD Cutaneous Syndrome: An Update
por: Nagy, Nikoletta, et al.
Publicado: (2021)

Gynaecological cylindroma in association with CYLD gene mutation
por: Khoury, Emma, et al.
Publicado: (2022)

Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation
por: Erol, Adnan
Publicado: (2022)

CYLD inhibits melanoma growth and progression through suppression of the JNK/AP-1 and β1-integrin signaling pathways
por: Ke, Hengning, et al.
Publicado: (2012)

Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD
por: Komatsu, Kensei, et al.
Publicado: (2013)

Nuclear Expression of the Deubiquitinase CYLD Is Associated with Improved Survival in Human Hepatocellular Carcinoma
por: Welte, Stefan, et al.
Publicado: (2014)

TRIM15 and CYLD regulate ERK activation via lysine 63-linked polyubiquitination
por: Zhu, Guixin, et al.
Publicado: (2021)

Tracking tumor kinetics in patients with germline CYLD mutations
por: Brown, Sarah, et al.
Publicado: (2018)

CYLD dysregulation in pathogenesis of sporadic inclusion body myositis
por: Yamashita, Satoshi, et al.
Publicado: (2019)

IKK-mediated CYLD phosphorylation and cellular redox activity
por: Erol, Adnan
Publicado: (2022)

miR-186 suppressed CYLD expression and promoted cell proliferation in human melanoma
por: Qiu, Haijiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tksedb7vnmrnrs7odnmcfle1ln